(Q35202874)

7 August 2017

1 reference

title

Phospholipase A2 expression in tumours: a target for therapeutic intervention? (English)

1 reference

7 August 2017

Jonathan P Laye

1

1 reference

7 August 2017

Jason H Gill

series ordinal

2

1 reference

7 August 2017

publication date

1 August 2003

1 reference

7 August 2017

1 reference

7 August 2017

volume

8

1 reference

7 August 2017

issue

15

1 reference

7 August 2017

page(s)

710-716

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 August 2017

1 reference

7 January 2021

Prostaglandins as modulators of immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

A causal relationship between unscheduled eicosanoid signaling and tumor development: cancer chemoprevention by inhibitors of arachidonic acid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologies

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Mammalian phospholipases A(2): mediators of inflammation, proliferation and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Biological effects of group IIA secreted phosholipase A(2).

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Roles of secretory phospholipases A(2) in inflammatory diseases and trauma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Cytokine regulation of group II phospholipase A2 expression in glomerular mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Transcriptional regulation of inflammatory secreted phospholipases A(2).

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Enhanced expression of group II phospholipase A2 gene in the tissues of endotoxin shock rats and its suppression by glucocorticoid.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Neutrophil response of transgenic mice expressing human group IIA phospholipase A2 in bacterial infections

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Overexpression of secretory phospholipase A(2) causes rapid catabolism and altered tissue uptake of high density lipoprotein cholesteryl ester and apolipoprotein A-I

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Expression of group IIA secretory phospholipase A2 is elevated in prostatic intraepithelial neoplasia and adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Expression of group-II phospholipase A2 in malignant and non-malignant human gastric mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Immunohistochemical localization of group II phospholipase A2 in the tumours and mucosa of the colon and rectum

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

COX-2, Inflammatory Secreted PLA2, and Cytoplasmic PLA2 Protein Expression in Small Bowel Adenocarcinomas Compared with Colorectal Adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Secretory type II phospholipase A2 (PLA2G2A) expression status in colorectal carcinoma derived cell lines and in normal colonic mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Molecular analysis of the secretory phospholipase A2 gene, a candidate of Mom1 gene, in neuroblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Variants at the secretory phospholipase A2 (PLA2G2A) locus: analysis of associations with familial adenomatous polyposis and sporadic colorectal tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Lack of phospholipase A2 mutations in neuroblastoma, melanoma and colon-cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

The effect of phospholipase A2 inhibitors on proliferation and apoptosis of murine intestinal cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Phospolipase A2 and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Control of capillary formation by membrane-anchored extracellular inhibitor of phospholipase A(2)

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Exclusion of Madh2, Madh4, and Madh7 as candidates for the modifier of Min 2 (Mom2) locus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Identification of the modifier of Min 2 (Mom2) locus, a new mutation that influences Apc-induced intestinal neoplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Inhibition of phospholipase A(2) as a therapeutic target

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

New weapons against inflammation: dual inhibitors of phospholipase A2 and transglutaminase.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Regulation and inhibition of phospholipase A2.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Secreted phospholipase A(2) as a new enzymatic trigger mechanism for localised liposomal drug release and absorption in diseased tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Synthesis of a novel phosphatidylcholine conjugated to docosahexaenoic acid and methotrexate that inhibits cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Multiple splice variants of the human calcium-independent phospholipase A2 and their effect on enzyme activity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Antisense inhibition of group VI Ca2+-independent phospholipase A2 blocks phospholipid fatty acid remodeling in murine P388D1 macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Calcium-independent phospholipase A(2): structure and function.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

The functions of five distinct mammalian phospholipase A2S in regulating arachidonic acid release. Type IIa and type V secretory phospholipase A2S are functionally redundant and act in concert with cytosolic phospholipase A2

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Distinct roles of two intracellular phospholipase A2s in fatty acid release in the cell death pathway. Proteolytic fragment of type IVA cytosolic phospholipase A2alpha inhibits stimulus-induced arachidonate release, whereas that of type VI Ca2+-inde

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Molecular cloning of two new human paralogs of 85-kDa cytosolic phospholipase A2

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Localization and regulation of cytosolic phospholipase A(2).

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

cPLA2 is phosphorylated and activated by MAP kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Serine 727 phosphorylation and activation of cytosolic phospholipase A2 by MNK1-related protein kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Fatty acid and phospholipid selectivity of different phospholipase A2 enzymes studied by using a mammalian membrane as substrate

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Expression of cytosolic and group X secretory phospholipase A(2) genes in human colorectal adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Induction of cytosolic phospholipase A2 by oncogenic Ras in human non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

COX-2 inhibitors in cancer treatment and prevention, a recent development

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Induction of cPLA2 in lung epithelial cells and non-small cell lung cancer is mediated by Sp1 and c-Jun

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Deletion of cytosolic phospholipase A(2) suppresses Apc(Min)-induced tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Inverse association between phospholipase A2 and COX-2 expression during mouse colon tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

Functional coupling between secretory phospholipase A2 and cyclooxygenase-2 and its regulation by cytosolic group IV phospholipase A2

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902754-5

7 January 2021

10.1016/S1359-6446(03)02754-5

Identifiers

DOI

1 reference

7 August 2017

1 reference